📰 TDD Lab Congratulates Dr. Parth Sarthi Sen Gupta on Times of India Recognition for COVID-19 Cardiovascular Study! 🎉

We are proud to announce that Dr. Parth Sarthi Sen Gupta recent study, published in ACS Pharmacology & Translational Science, has been featured in the Times of India for its impactful findings on cardiovascular complications in COVID-19 survivors.

Read the coverage: Research finds link to surge in heart ailments in Covid survivors | Bhubaneswar News - Times of India

The study explores the mechanistic link between COVID-19 and the observed increase in heart ailments among recovered individuals. Key findings include:

• The SARS-CoV-2 spike protein’s interaction with ACE2 receptors in heart tissues, potentially impairing normal cardiac function.

• Evidence that the spike protein may bind to fibrinogen, encouraging clot formation, which raises the risk of heart attacks and strokes.

• Insights into how these molecular disruptions may suppress immune responses, leaving patients vulnerable even after recovery.

This study offers important contributions to our understanding of long COVID effects and may guide therapeutic strategies for cardiovascular care in post-COVID patients.

Being featured in The Times of India underscores the clinical relevance and national importance of this work. We congratulate Dr. Parth and his collaborators for addressing a timely and critical public health issue with such scientific clarity.

Once again, well done Dr. Parth! Your work continues to shine a light on the hidden impacts of COVID-19 and inspires translational research for better patient care.